167 related articles for article (PubMed ID: 37749605)
1. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma.
McGowan E; Sanjak J; Mathé EA; Zhu Q
Orphanet J Rare Dis; 2023 Sep; 18(1):301. PubMed ID: 37749605
[TBL] [Abstract][Full Text] [Related]
2. Integrative Rare Disease Biomedical Profile based Network Supporting Drug Repurposing, a case study of Glioblastoma.
McGowan E; Sanjak J; Mathé EA; Zhu Q
Res Sq; 2023 Apr; ():. PubMed ID: 37131675
[No Abstract] [Full Text] [Related]
3. Drug repurposing for glioblastoma based on molecular subtypes.
Chen Y; Xu R
J Biomed Inform; 2016 Dec; 64():131-138. PubMed ID: 27697594
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral Drug Repositioning for Glioblastoma.
Rivas SR; Mendez Valdez MJ; Chandar JS; Desgraves JF; Lu VM; Ampie L; Singh EB; Seetharam D; Ramsoomair CK; Hudson A; Ingle SM; Govindarajan V; Doucet-O'Hare TT; DeMarino C; Heiss JD; Nath A; Shah AH
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730705
[TBL] [Abstract][Full Text] [Related]
5. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.
Persico M; Abbruzzese C; Matteoni S; Matarrese P; Campana AM; Villani V; Pace A; Paggi MG
Cells; 2022 Jan; 11(2):. PubMed ID: 35053377
[TBL] [Abstract][Full Text] [Related]
6. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
[TBL] [Abstract][Full Text] [Related]
7. Repurposing an Antiepileptic Drug for the Treatment of Glioblastoma.
Yadav A; Alnakhli A; Vemana HP; Bhutkar S; Muth A; Dukhande VV
Pharm Res; 2022 Nov; 39(11):2871-2883. PubMed ID: 36195821
[TBL] [Abstract][Full Text] [Related]
8. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M
Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558
[TBL] [Abstract][Full Text] [Related]
9. An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma.
Lyne SB; Yamini B
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919596
[TBL] [Abstract][Full Text] [Related]
10. EGeRepDR: An enhanced genetic-based representation learning for drug repurposing using multiple biomedical sources.
Muniyappan S; Rayan AXA; Varrieth GT
J Biomed Inform; 2023 Nov; 147():104528. PubMed ID: 37858852
[TBL] [Abstract][Full Text] [Related]
11. Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.
Jones D; Whitehead CA; Dinevska M; Widodo SS; Furst LM; Morokoff AP; Kaye AH; Drummond KJ; Mantamadiotis T; Stylli SS
Mol Cell Biochem; 2023 Jun; 478(6):1251-1267. PubMed ID: 36302993
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma as a Novel Drug Repositioning Target: Updated State.
Hosseinalizadeh H; Ebrahimi A; Tavakoli A; Monavari SH
Anticancer Agents Med Chem; 2023; 23(11):1253-1264. PubMed ID: 36733195
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties.
Volmar MNM; Cheng J; Alenezi H; Richter S; Haug A; Hassan Z; Goldberg M; Li Y; Hou M; Herold-Mende C; Maire CL; Lamszus K; Flüh C; Held-Feindt J; Gargiulo G; Topping GJ; Schilling F; Saur D; Schneider G; Synowitz M; Schick JA; Kälin RE; Glass R
Neuro Oncol; 2021 Nov; 23(11):1898-1910. PubMed ID: 33864076
[TBL] [Abstract][Full Text] [Related]
14. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
Elife; 2017 Sep; 6():. PubMed ID: 28936969
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma.
Benavides-Serrato A; Saunders JT; Holmes B; Nishimura RN; Lichtenstein A; Gera J
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948038
[TBL] [Abstract][Full Text] [Related]
16. Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond.
Daisy Precilla S; Kuduvalli SS; Thirugnanasambandhar Sivasubramanian A
Cell Biol Int; 2021 Jan; 45(1):18-53. PubMed ID: 33049091
[TBL] [Abstract][Full Text] [Related]
17. Drug Repositioning in Glioblastoma: A Pathway Perspective.
Tan SK; Jermakowicz A; Mookhtiar AK; Nemeroff CB; Schürer SC; Ayad NG
Front Pharmacol; 2018; 9():218. PubMed ID: 29615902
[TBL] [Abstract][Full Text] [Related]
18. Metabolic modeling-based drug repurposing in Glioblastoma.
Tomi-Andrino C; Pandele A; Winzer K; King J; Rahman R; Kim DH
Sci Rep; 2022 Jul; 12(1):11189. PubMed ID: 35778411
[TBL] [Abstract][Full Text] [Related]
19. An effective multi-task learning framework for drug repurposing based on graph representation learning.
Ye S; Zhao W; Shen X; Jiang X; He T
Methods; 2023 Oct; 218():48-56. PubMed ID: 37516260
[TBL] [Abstract][Full Text] [Related]
20. Repurposing drugs for glioblastoma: From bench to bedside.
Basso J; Miranda A; Sousa J; Pais A; Vitorino C
Cancer Lett; 2018 Aug; 428():173-183. PubMed ID: 29729291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
